CN107137466A - The preparation method of liver-protection health-care composition - Google Patents

The preparation method of liver-protection health-care composition Download PDF

Info

Publication number
CN107137466A
CN107137466A CN201710354908.6A CN201710354908A CN107137466A CN 107137466 A CN107137466 A CN 107137466A CN 201710354908 A CN201710354908 A CN 201710354908A CN 107137466 A CN107137466 A CN 107137466A
Authority
CN
China
Prior art keywords
buckwheat
liver
ethanol
potassium
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710354908.6A
Other languages
Chinese (zh)
Inventor
刘宏
王焕芸
白玉琴
马宇衡
布仁
阿古拉
包哈申
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inner Mongolia Medical University
Original Assignee
Inner Mongolia Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inner Mongolia Medical University filed Critical Inner Mongolia Medical University
Priority to CN201710354908.6A priority Critical patent/CN107137466A/en
Publication of CN107137466A publication Critical patent/CN107137466A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/53Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of preparation method of liver-protection health-care composition, comprise the following steps:Carry out the extraction of flavones and buckwheat polysaccharide;After the buckwheat flavone of gained and buckwheat polysaccharide are crushed, cross after 80 mesh sieves, weigh buckwheat polysaccharide 10kg, buckwheat flavone 2.5kg, sesamin 100g, gossypose 2kg, be well mixed, plus appropriate dextrin, stir, 80% ethanol softwood, the granulation of 20 mesh sieves, dry to moisture and be no more than 8%, 10 mesh sieve whole grains, packing, every bag of 7g.The present invention is by optimization of C/C composites, and will take stopgap measures and effect a permanent cure is combined, and realizes recent relief of symptoms, and long term recovers the effect of liver function.

Description

The preparation method of liver-protection health-care composition
Technical field
The present invention relates to health medicine field, and in particular to a kind of preparation method of liver-protection health-care composition.
Background technology
Alcoholic liver, full name is alcoholic fatty liver, is occurred earliest in AML, most commonly seen lesion.Alcohol Liver is due to the hepar damnification disease caused by long-term heavy drinking or excessive drinking.Long-term wine-head 60~90% suffers from Alcoholic fat Fat liver, alcoholic liver not only influences the synthesis of protein and vitamin to absorb (malnutrition), and malnutritive as liver cell The secondary factors further damaged, influence each other the fatty infiltration for ultimately resulting in liver cell, inflammation, necrosis, liver fibrosis, liver The generation of hardening.In addition, can also trigger multiple complications, these complication are often the hazards for causing alcoholic liver dead:
1. UGB:Portal hypertension caused by alcoholic liver, mostly occur UGB, it is also possible to due to urgency Property gastric erosion, canker or esophageal varices bleeding (EVB), if timely and effectively can not handle and tackle, can go out Situations such as now suffering a shock crisis life, dead probability is higher.
2. ascites and infection:Alcoholic liver causes a large amount of ascites occur because of factors such as electrolyte, osmotic pressure, nutrition, is similar to The ascites of hepatic sclerosis and hepatocarcinoma patient, therefore cause vicious circle electrolyte disturbance or crisis whole system easily occur to cause It is dead.Simultaneously because nutrition and various complication factors in the alcoholic liver course of disease, cause hypoimmunity easily to infect, particularly lung Infect and bacillary spontaneous peritonitis in portion.The incidence of pneumonia is higher than in crowd 3-4 times, and is one of important cause of death, Therefore it is prevented and treated should be in attention.
3. hepatic encephalopathy (hepatic coma):Alcoholic liver patient Duo Yin hemorrhages of digestive tract, electrolyte and acid-base disturbance, secondary sense Dye, etc. factor, complicated mechanism causes in itself with disease.If when occurring hepatic coma, rescue is improper or not in time, dead Rate is high, should start with for alcoholic liver patient from prevention above risk factor, while active treatment alcoholic liver.
4. electrolyte disturbance, acid-base imbalance:Alcohol metabolism produces hyperlactacidemia, ketosis, causes AG (between anion Gap) metabolic acidosis, ethanol, which excessively anaesthetizes suppression breathing, can cause respiratory acidosis, and alcohol withdrawal syndrome hyperpnea hyperventilation can cause to exhale Absorption alkalosis.Simultaneously because take in less, drain acid-base disturbance caused by many, intestines and stomach and renal tubule malabsorption and ethanol, There is electrolyte disturbance, occur low potassium, low magnesium, low calcium, hypophosphatemia etc., be to cause the major reason of death.
The ratio of China wine-head is significantly raised, and therefore the incidence of disease of alcoholic liver also significantly rises, and in rejuvenation trend, Have become the second largest liver diseases for being only second to virus hepatitis.With the increase year by year for population of being addicted to drink, AML is Through as role very important in hepatopathy family.The alcohol consumption speed fast 56% more increased than world other countries of China Male and 15% women are on the drink, and men and women's percentage of wherein heavy drinking is respectively 51% and 63%, the percentage of excessive drinking Than being respectively 57% and 27%.There is statistics to show, the alcoholic liver illness rate of white collar crowd and relatively rich crowd is up to 13~ 24%.Cut-off 2011, China male alcoholic liver illness rate is 6.36%, and women is 0.36%;Male is addicted to drink crowd's alcoholic liver Illness rate is 21.77%, and women is addicted to drink crowd 1.26%.Conservative estimation China alcoholic liver patient numbers should 50,000,000 or so, As treated not in time, 60% alcohol hepatopath finally translates into hepatic sclerosis even liver cancer.
Existing hepatinica mainly has several classes such as yellow drop, drop enzyme, removing toxic substances.Showing as taking stopgap measures effect more, and long-term prescription has one Determine adverse reaction, some medicines are also possible to cause liver function to rebound after being discontinued.
Polysaccharide has good anti-liver injury effect, is mainly damaged by Green Tea Extract, resists Calcium within hepatocytes overload, regulation Mitochondrial function etc. plays anti-chemical damage effect, and by adjusting cell factor, suppressing complement system activity, suppression inflammation Property medium produce, prevent hepatocellular apoptosis etc. play anti-immune hepatic injury effect.
Experimental studies have found that duck wheat polysaccharide has obvious scavenging action to DPPH free radicals.Under same concentrations, polysaccharide V is significantly better than to the elimination effect of DPPH free radicalsCAnd VERemoving to DPPH free radicals.
Separately there is studies have shown that buckwheat polysaccharide to have significantly carbon tetrachloride, paracetamol induced mice acute liver damage Protective effect.
Buckwheat flavone can reduce the death rate and Body weight loss rate of alcoholic liver injury mouse, suppress hepatic injury mouse LI, AST and MDA, significantly increase hepatic injury murine liver tissue SOD activity, and the morphology for significantly improving alcohol damaged liver cell becomes Change, the mechanism that its alcoholic liver injury has significant protective effect may be relevant with anti-lipid peroxidation damage.
Sesamin can significantly improve acute liver damage caused by paracetamol, mitigate the subacute hepatic injury caused by alcohol, Reduce CCl4To the chronic injury of liver, suppress or delay the fibrosis of liver.Sesamin can make acute hepatic injury mice serum ALT, GST are substantially reduced, and liver homogenate MDA contents are not only substantially less than model group, also less than normal group, illustrate that sesamin can make liver Cytolipin extent of peroxidation substantially mitigates.Make the significantly rise of rats'liver SOD activity after sesamin long-time medication, point out sesame Plain long-term prescription, antioxidation not only with short-term medication when direct effect of scavenging radical it is relevant, Shang Yuqi can improve SOD Activity is relevant.Pathological examination is shown, sesamin is taken for a long time, can make animal pattern swelling of liver cell and steatosis degree Mitigate.
Gossypose is neither degraded nor absorbed in small intestine, into large intestine just by Bifidobacterium and lactobacillus acidophilus profit With promotion Bifidobacterium propagation, is the proliferation factor of Bifidobacterium.Cotton seed oligosaccharide can adjust bacterial equilibrium in enteron aisle, extensive Multiple intestinal wall original state simultaneously forms protective layer, protects intestinal health.A large amount of generations of harmful substance in enteron aisle can be prevented, mitigate liver Burden, so as to play a part of preventing and treat various hepatopathy diseases.
The content of the invention
To solve the above problems, the invention provides a kind of preparation method of liver-protection health-care composition, by taking stopgap measures and controlling Originally it is combined, realizes recent relief of symptoms, long term recovers the effect of liver function.
To achieve the above object, the technical scheme taken of the present invention is:
The preparation method of liver-protection health-care composition, comprises the following steps:
S1, buckwheat or flowers and leaves of buckwheat are taken, crushed, plus 40%~90% ethanol, immersion, heating extraction, extract solution adds The fining agents of ZTC- II, are stirred, and insulation is stood, filtering, filtrate decompression concentration, and concentrate adjusts pH value to acidity, and stirring is equal It is even, stand, filtering, solid adds ethanol to dissolve, filter, filtrate recycling ethanol, remaining liq spray drying obtains buckwheat flavone;
S2, in the buckwheat after extracting buckwheat flavone Jia 0.1~1.5% salt solution, heating stirring extraction, extract solution adds The fining agents of ZTC- II, are stirred, and insulation is stood, filtering, filtrate decompression concentration, plus 3~95% ethanol of 15 times of amounts, and stirring is equal It is even, stand, filtering, solid is dissolved in water, plus 3~5 times of 80% ethanol of amount, stir, stand, filter, dry, obtain buckwheat many Sugar;
S3, the buckwheat flavone of gained and buckwheat polysaccharide are crushed after, cross after 80 mesh sieves, weigh buckwheat polysaccharide 10kg, buckwheat Flavones 2.5kg, sesamin 100g, gossypose 2kg, are well mixed, plus appropriate dextrin, stir, 80% ethanol softwood, 20 Mesh sieve is pelletized, and is dried to moisture and is no more than 8%, 10 mesh sieve whole grains, packing, every bag of 7g.
Wherein, the salt solution is sodium chloride, potassium chloride, sodium carbonate, sodium acid carbonate, sodium sulphate, potassium sulfate, sodium phosphate, phosphorus Any in sour potassium, potassium carbonate, disodium hydrogen phosphate, dipotassium hydrogen phosphate, sodium dihydrogen phosphate, potassium dihydrogen phosphate, sodium nitrate, potassium nitrate Kind.
The present invention is by optimization of C/C composites, and will take stopgap measures and effect a permanent cure is combined, and realizes recent relief of symptoms, and long term recovers liver function Effect.
Embodiment
In order that objects and advantages of the present invention are more clearly understood, the present invention is carried out with reference to embodiments further Describe in detail.It should be appreciated that the specific embodiments described herein are merely illustrative of the present invention, it is not used to limit this hair It is bright.
The embodiments of the invention provide a kind of preparation method of liver-protection health-care composition, comprise the following steps:
S1, buckwheat or flowers and leaves of buckwheat are taken, crushed, plus 40%~90% ethanol, immersion, heating extraction, extract solution adds The fining agents of ZTC- II, are stirred, and insulation is stood, filtering, filtrate decompression concentration, and concentrate adjusts pH value to acidity, and stirring is equal It is even, stand, filtering, solid adds ethanol to dissolve, filter, filtrate recycling ethanol, remaining liq spray drying obtains buckwheat flavone;
S2, in the buckwheat after extracting buckwheat flavone Jia 0.1~1.5% salt solution, heating stirring extraction, extract solution adds The fining agents of ZTC- II, are stirred, and insulation is stood, filtering, filtrate decompression concentration, plus 3~95% ethanol of 15 times of amounts, and stirring is equal It is even, stand, filtering, solid is dissolved in water, plus 3~5 times of 80% ethanol of amount, stir, stand, filter, dry, obtain buckwheat many Sugar;
S3, the buckwheat flavone of gained and buckwheat polysaccharide are crushed after, cross after 80 mesh sieves, weigh buckwheat polysaccharide 10kg, buckwheat Flavones 2.5kg, sesamin 100g, gossypose 2kg, are well mixed, plus appropriate dextrin, stir, 80% ethanol softwood, 20 Mesh sieve is pelletized, and is dried to moisture and is no more than 8%, 10 mesh sieve whole grains, packing, every bag of 7g, the 3g of polysaccharide containing buckwheat, buckwheat flavone 0.75g, sesamin 0.030g, gossypose 0.60g;1 bag every time, 3 times a day, warm boiled water.
The salt solution be sodium chloride, potassium chloride, sodium carbonate, sodium acid carbonate, sodium sulphate, potassium sulfate, sodium phosphate, potassium phosphate, Any of potassium carbonate, disodium hydrogen phosphate, dipotassium hydrogen phosphate, sodium dihydrogen phosphate, potassium dihydrogen phosphate, sodium nitrate, potassium nitrate.
Described above is only the preferred embodiment of the present invention, it is noted that for the ordinary skill people of the art For member, under the premise without departing from the principles of the invention, some improvements and modifications can also be made, these improvements and modifications also should It is considered as protection scope of the present invention.

Claims (2)

1. the preparation method of liver-protection health-care composition, it is characterised in that comprise the following steps:
S1, buckwheat or flowers and leaves of buckwheat are taken, crushed, plus 40%~90% ethanol, immersion, heating extraction, extract solution adds ZTC- II Fining agent, is stirred, and insulation is stood, filtering, and filtrate decompression concentration, concentrate adjusts pH value to acidity, stirs, quiet Put, filter, solid adds ethanol to dissolve, filter, filtrate recycling ethanol, remaining liq spray drying obtains buckwheat flavone;
S2, in the buckwheat after extracting buckwheat flavone Jia 0.1~1.5% salt solution, heating stirring extraction, extract solution adds ZTC- II Fining agent, stirs, insulation stand, filtering, filtrate decompression concentration, plus 3~15 times amount 95% ethanol, stir, it is quiet Put, filter, solid is dissolved in water, plus 3~5 times of 80% ethanol of amount, stir, stand, filter, dry, obtain buckwheat polysaccharide;
S3, the buckwheat flavone of gained and buckwheat polysaccharide are crushed after, cross after 80 mesh sieves, weigh buckwheat polysaccharide 10kg, buckwheat flavone 2.5kg, sesamin 100g, gossypose 2kg, are well mixed, plus appropriate dextrin, stir, 80% ethanol softwood, 20 mesh sieves Granulation, dries to moisture and is no more than 8%, 10 mesh sieve whole grains, packing, every bag of 7g.
2. the preparation method of liver-protection health-care composition as claimed in claim 1, it is characterised in that the salt solution be sodium chloride, Potassium chloride, sodium carbonate, sodium acid carbonate, sodium sulphate, potassium sulfate, sodium phosphate, potassium phosphate, potassium carbonate, disodium hydrogen phosphate, phosphoric acid hydrogen two Any of potassium, sodium dihydrogen phosphate, potassium dihydrogen phosphate, sodium nitrate, potassium nitrate.
CN201710354908.6A 2017-05-19 2017-05-19 The preparation method of liver-protection health-care composition Pending CN107137466A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710354908.6A CN107137466A (en) 2017-05-19 2017-05-19 The preparation method of liver-protection health-care composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710354908.6A CN107137466A (en) 2017-05-19 2017-05-19 The preparation method of liver-protection health-care composition

Publications (1)

Publication Number Publication Date
CN107137466A true CN107137466A (en) 2017-09-08

Family

ID=59777609

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710354908.6A Pending CN107137466A (en) 2017-05-19 2017-05-19 The preparation method of liver-protection health-care composition

Country Status (1)

Country Link
CN (1) CN107137466A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101045720A (en) * 2007-03-20 2007-10-03 陕西师范大学 Method for extracting buckwheat flavone from buckwheat shell
CN101829196A (en) * 2010-05-26 2010-09-15 南京泽朗农业发展有限公司 Preparation method of high-content buckwheat total flavone
CN102977218A (en) * 2012-10-13 2013-03-20 内蒙古清谷新禾有机食品集团有限责任公司 Method for extracting polysaccharide from buckwheat brans
CN106138240A (en) * 2016-08-01 2016-11-23 四川农业大学 A kind of extracting method of buckwheat total flavone

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101045720A (en) * 2007-03-20 2007-10-03 陕西师范大学 Method for extracting buckwheat flavone from buckwheat shell
CN101829196A (en) * 2010-05-26 2010-09-15 南京泽朗农业发展有限公司 Preparation method of high-content buckwheat total flavone
CN102977218A (en) * 2012-10-13 2013-03-20 内蒙古清谷新禾有机食品集团有限责任公司 Method for extracting polysaccharide from buckwheat brans
CN106138240A (en) * 2016-08-01 2016-11-23 四川农业大学 A kind of extracting method of buckwheat total flavone

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
达胡白乙拉等: "荞麦花多糖的提取及含量测定", 《光谱实验室》 *

Similar Documents

Publication Publication Date Title
Sabu et al. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes
Hou et al. Protective effects of a Lachnum polysaccharide against liver and kidney injury induced by lead exposure in mice
CN104223107B (en) A kind of health products of liver-protecting and alcoholism-relieving toxin expelling
CN101932238A (en) Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products
Lee et al. Hypoglycemic effect of Sargassum ringgoldianum extract in STZ-induced diabetic mice
Zhang et al. The protective mechanisms of macroalgae Laminaria japonica consumption against lipid metabolism disorders in high-fat diet-induced hyperlipidemic rats
Abdel-Reheim et al. Effect of food additives (monosodium glutamate and sodium nitrite) on some biochemical parameters in albino rats
Zhao et al. Zinc alleviates arsenism in common carp: varied change profiles of cytokines and tight junction proteins among two intestinal segments
Moradi et al. Medicinal properties of Persian shallot
Ige et al. Oral magnesium reduces gastric mucosa susceptibility to injury in experimental diabetes mellitus
CN103446174A (en) Application of mannuronic acid oligomers in preparing medicines, health products or dietary supplements for preventing and treating alcoholic liver injury
CN105558198A (en) Health-care tea capable of reducing blood sugar and preparation method of health-care tea
Rao et al. Insulin stimulative and anti-oxidative effects of Persea americana fruit extract on streptozotocin induced hyperglycemic rats
Govindan et al. Antidiabetic activity of polysaccharide from Hypsizygus ulmarius in streptozotocin-nicotinamide induced diabetic rats
Yu et al. AP39 ameliorates high fat diet-induced liver injury in young rats via alleviation of oxidative stress and mitochondrial impairment
CN110742267A (en) Total-nutrient formula food for inflammatory bowel diseases
CN104432063A (en) Composition for alleviating athletic fatigue and preparation method thereof
CN104366037A (en) Aquatic product liver and gallbladder syndrome control feed additive and preparation method thereof
CN104208117A (en) Plant extract compound product with function of maintaining liver
JP2003246738A (en) Magnesium-fortification liquid and moisturizer, cosmetic and beverage using this
CN107137466A (en) The preparation method of liver-protection health-care composition
CN102755393B (en) Medicament for treating hepatopathy and preparation method thereof
CN108570116A (en) Yellowish green frizzle mushroom polysaccharide and preparation method and the medical application in preventing diabetes
Catal et al. Protective effects of antioxidant combination against D‐galactosamine‐induced kidney injury in rats
CN105232588B (en) A kind of health food and preparation method with protection alcoholic liver injury effect

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170908